Quince Therapeutics, Inc. (QNCX)
1.41
+0.05
(+3.45%)
USD |
NASDAQ |
Apr 13, 16:00
1.33
-0.08
(-5.67%)
After-Hours: 04:12
Quince Therapeutics Cash from Investing (TTM) : 23.23M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Recursion Pharmaceuticals, Inc. | -16.87M |
| Ocular Therapeutix, Inc. | -11.88M |
| Gossamer Bio, Inc. | 156.36M |
| Ernexa Therapeutics, Inc. | -0.037M |
| Acurx Pharmaceuticals, Inc. | 0.00 |